Clinical denials not human scale strain hospital resources as payers shift to complex back-end reviews, increasing financial and administrative burdens.

Bezos AI venture, Project Prometheus, nears $10B fundraising, valued at $38B, focusing on physics-based AI for manufacturing ...

Recurring revenue mix -- 99% of revenue was recurring, providing high predictability and revenue visibility. Customer ...

Every "18" product must clear three criteria before reaching market - a patented ingredient, peer-reviewed clinical evidence, and the exact dose studied in clinical ...

Dexcom develops continuous glucose monitoring (CGM) devices. Diabetic patients use these to track their glucose levels in ...

Adds Scaled, Integrated Productivity Solutions Platform with Strong Positions Across Key VerticalsExpands Total Addressable Market and Opens Enterprise Customer ChannelImmediately Double-Digit ...

Acquisition will bring industry-leading Silicon Photonics PIC technology in-house, expanding Credo's addressable market and deepening its optical interconnect portfolio across 800G, 1.6T, and 3.2T NPO ...

Hesai announces a strategic shift to spatial intelligence, introducing Kosmo, a new spatial intelligence AI hardware platform ...

A more fragmented world marked by war, trade rivalry and geopolitical mistrust may be strengthening rather than weakening the ...

Class A shares of the Alger Capital Appreciation Fund underperformed the Russell 1000 Growth Index during the first quarter ...

SALT LAKE CITY, April 15, 2026 (GLOBE NEWSWIRE) -- OMNIQ CORP. (OTCMKTS: OMQS) (“OMNIQ” or “the Company”) reports year-end 2025 revenue of $33 million and a 60% increase in gross profit compared to ...

TopBuild Corp. BLD is set to be acquired by QXO, Inc. QXO under a definitive agreement unanimously agreed upon by their ...